New anti-reflux stopper aims to cut catheter complications
NCT ID NCT07519304
First seen Apr 19, 2026 · Last updated Jun 19, 2026 · Updated 12 times
Summary
This study tests a special stopper (needle-free connector) with anti-reflux technology on long catheters placed in arm veins of hospitalized adults. The goal is to see if it reduces problems like blockages, infections, and pain compared to a standard stopper. About 62 patients who need a catheter for at least a week will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RANDOMISED CONTROLLED TRIAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Needle-free connector with anti-reflux technology
What this could lead to
If it works, this could reduce catheter-related complications such as blockages and infections, making hospital stays safer and more comfortable.
What could go wrong
This is a small early-stage trial with only 62 participants, so results may not apply to all patients. The device may not significantly reduce complications.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.